← Home
Boise Cascade
-8.16%
Wood / Forest products
Press Releases
| Date | Press release |
|---|---|
| 2025-04-22 16:15:00 | Boise Cascade Company First Quarter 2025 Earnings Webcast And Conference Call Boise, idaho--(business wire)--boise cascade company (nyse: bcc) will host a webcast and conference call to discuss 2025 first quarter earnings on tuesday, may 6, 2025, at 9:30 a.m. eastern. to join the webcast, go to the investors section of our website at www.bc.com/investors and select the event calendar link. analysts and investors who wish to ask questions during the q&a session can register for the call here. the archived webcast will be available in the investors section of boise cas. |
| 2025-04-21 07:30:00 | Medicus Pharma Provides Update On Sknjct-003 Phase 2 Clinical Study For The Treatment Of Nodular Basal Cell Carcinoma (bcc) The institutional review board has approved the increase in number of patients from sixty (60) to ninety (90). the company to expand the study into additional trial sites in europe philadelphia, pennsylvania--(newsfile corp. - april 21, 2025) - medicus pharma ltd. |
| 2025-03-06 07:30:00 | Medicus Pharma Ltd Announces Positively Trending Interim Analysis For Sknjct-003 Phase 2 Clinical Study To Non-invasively Treat Basal Cell Carcinoma Of The Skin (bcc) The interim analysis showed complete clinical clearance of more than sixty (60%) percent philadelphia, pennsylvania--(newsfile corp. - march 6, 2025) - medicus pharma ltd. (nasdaq: mdcx) (\"medicus\" or the \"company\") is pleased to announce a positively trending interim analysis for sknjct-003 phase 2 clinical study to non-invasively treat basal cell carcinoma of the skin (bcc). |
| 2025-02-27 07:30:00 | Medicus Pharma Ltd Announces Submission Of Phase 2 Clinical Design (sknjct-004) To United Arab Emirates (uae) Department Of Health (doh) To Non-invasively Treat Basal Cell Carcinoma Of The Skin (bcc) The clinical study is expected to randomize 36 participants in cleveland clinic abu dhabi (ccad) and three other clinical sites in uae the clinical study is expected to randomize 36 participants in cleveland clinic abu dhabi (ccad) and three other clinical sites in uae |
| 2025-02-21 16:10:00 | Boise Cascade Promotes Nathan Sikes To Senior Vice President Of Western Operations For Building Materials Distribution Division Boise, idaho--(business wire)--boise cascade company (boise cascade) (nyse: bcc) announced today that nathan sikes will be the new senior vice president of western operations for their building materials distribution (bmd) division, effective february 24, 2025. in this role, nathan will be responsible for bmd’s facilities and door shops located in the western and pacific regions. since joining boise cascade in 2006, nathan has held a series of key roles and progressive leadership positions in t. |
© 2024 - 2025 InsightfulValue.com. All rights reserved.
Legal